New

Asia Pacific Immunohistochemistry Market

2021

Asia Pacific Immunohistochemistry Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Diagnostics and Drug Testing), Product (Antibodies, Equipment, Reagents, and Kits), and End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others)

Publication Month: Nov 2021 | Report Code: TIPRE00025746 | No. of Pages: 150 | Category: Biotechnology | Status: Published

Market Insights

Asia Pacific Immunohistochemistry Market to Grow at a CAGR of 7.8% to reach US$ 818.00 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The APAC immunohistochemistry market is expected to grow from US$ 483.76 million in 2021 to US$ 818.00 million by 2028; it is estimated to grow at a CAGR of 7.8% from 2021 to 2028.

China, Japan, India, Australia, and South Korea are major economies in APAC. Burgeoning opportunities in emerging countries is expected to fuel the market growth. The emerging markets across the region are creating significant opportunities for the key market players to expand their business. It is likely to be a prime factor contributing to the market growth during the coming years. Majority of the players concentrate on developing markets, owing to the large population suffering from chronic diseases in the region. With rising costs of production against their practices, the healthcare companies are striving to produce sufficient revenue to entertain their investors. The markets in some growing economies are expected to be an essential part of offering more reliable and profitable growth opportunities for the major players to expand their industry scope. Advancements in biotechnology have increased the demand for diagnostics in the healthcare market, encouraging the introduction of a more significant number of immunoassay systems and facilitating the shift toward personalized medicine. There are new opportunities in infectious disease testing, molecular oncology, and pharmacogenomics in emerging countries. Hence, healthcare companies can target patients or consumers in the region. There has been an increase in the healthcare expenditure of the countries during the previous years. Various players in the industry have been investing a significant amount of their revenue in research and development activities for the development of better and advanced products and technologies to be used in the healthcare industry. Presence of significant biopharmaceutical companies in the region and the growing number of local companies are the factors contributing to the market growth in the region. These activities in the region are increasing the demand for immunohistochemistry. Thus, the rising number of infectious disease incidences and advancements in emerging countries are likely to boost the market and are anticipated to provide significant growth opportunities to the players operating in the APAC market during the forecast period.

Countries in APAC, especially India, are highly affected due to the COVID-19 outbreak. The supply chain disturbances and the tremendous demand for efficient treatments for the therapy of COVID-19 have put the healthcare research industry in a crucial situation in APAC. Prohibitive measures have been taken to control the spread of the novel coronavirus. The COVID-19 pandemic has adversely affected economies in the region. The socioeconomics was severely affected, rising in negative inflation, GDPs, and a regional unemployment surge. Countries, such as China, Japan, Singapore, and South Korea, are seeing an increased interest in clinical trials. High costs in western countries are also contributing to the flow of medical affairs outsourcing to APAC. To expand sales to the Asian market, pharmaceutical companies are becoming aware of new and changing regulatory environments for drugs, devices, and in-vitro diagnostics. New or improved regulations are implemented frequently in Asia, including changes in GMP standards, drug price controls, and medical device regulatory systems. Third-party guidance and advice are required as a part of any acquisition or any improvement of current standards. Increasingly, third-party outsourcing service providers are playing a significant role in supporting the associated market in APAC. However, the market has stabilized compared to the initial phases of the pandemic owing to the control procedures, awareness among people, vaccination availability, and supportive government policies of the business in the related market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC immunohistochemistry market. The APAC immunohistochemistry market is expected to grow at a good CAGR during the forecast period.
APAC immunohistochemistry market

Get more information on this report :


APAC Immunohistochemistry Market Segmentation

APAC Immunohistochemistry Market – By Product

  • Equipment
    • Slide Staining Systems
    • Tissue Microarray Systems
    • Tissue Processing Systems
    • Slide Scanners
    • Other Equipment
  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Reagents
    • Histological Stains
    • Blocking and Fixation Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits

APAC Immunohistochemistry Market – By Application

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
    • Others
  • Drug Testing

APAC Immunohistochemistry Market – By End User

  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Others

APAC Immunohistochemistry Market, by Country

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

APAC Immunohistochemistry Market - Companies Mentioned

  • Abcam plc
  • Agilent Technologies, Inc.
  • Bio SB
  • BIO-RAD LABORATORIES INC.
  • Cell Signaling Technology, Inc.
  • Danaher
  • F. HOFFMANN-LA ROCHE LTD.
  • MERCK KGaA
  • PerkinElmer Inc.
  • THERMO FISHER SCIENTIFIC INC.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Immunohistochemistry Market – By Product

1.3.2 APAC Immunohistochemistry Market – By Application

1.3.3 APAC Immunohistochemistry Market – By End User

1.3.4 APAC Immunohistochemistry Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Immunohistochemistry Market – Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Immunohistochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Escalating Incidences of Chronic and Infectious Diseases

5.1.2 Surging R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2 Key Market Restraints

5.2.1 Complications Related to Immunohistochemistry

5.3 Key Market Opportunities

5.3.1 Burgeoning Opportunities in Emerging Countries

5.4 Future Trends

5.4.1 Growing Acceptance of Automation in Immunohistochemistry

5.5 Impact Analysis

6. Immunohistochemistry Market – APAC Analysis

6.1 APAC Immunohistochemistry Market Revenue Forecast and Analysis

7. APAC Immunohistochemistry Market Analysis– By Product

7.1 Overview

7.2 APAC Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3 Antibodies

7.3.1 Overview

7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3 Primary Antibodies

7.3.3.1 Overview

7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4 Secondary Antibodies

7.3.4.1 Overview

7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Equipment Market

7.4.1 Overview

7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3 Slide Staining Systems

7.4.3.1 Overview

7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4 Tissue Microarrays

7.4.4.1 Overview

7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5 Tissue Processing Systems

7.4.5.1 Overview

7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6 Slide Scanners

7.4.6.1 Overview

7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7 Other Equipments

7.4.7.1 Overview

7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Reagents Market

7.5.1 Overview

7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3 Histological Stains

7.5.3.1 Overview

7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4 Blocking Sera & Reagents Market

7.5.4.1 Overview

7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5 Chromogenic Substrates Market

7.5.5.1 Overview

7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6 Stabilizers

7.5.6.1 Overview

7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7 Proteolytic Enzymes

7.5.7.1 Overview

7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8 Organic Solvents

7.5.8.1 Overview

7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9 Fixation Reagents

7.5.9.1 Overview

7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10 Diluents

7.5.10.1 Overview

7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6 Kits Market

7.6.1 Overview

7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8. APAC Immunohistochemistry Market Analysis – By Application

8.1 Overview

8.2 APAC Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3 Diagnostics

8.3.1 Overview

8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3 Cancer

8.3.3.1 Overview

8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4 Infectious Diseases

8.3.4.1 Overview

8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5 Autoimmune Diseases

8.3.5.1 Overview

8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6 Diabetes Mellitus

8.3.6.1 Overview

8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7 Nephrological Diseases

8.3.7.1 Overview

8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8 Others

8.3.8.1 Overview

8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Drug Testing

8.4.1 Overview

8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9. APAC Immunohistochemistry Market Analysis– By End User

9.1 Overview

9.2 APAC Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3 Hospital & Diagnostic Laboratories

9.3.1 Overview

9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4 Research Institutes

9.4.1 Overview

9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5 Others

9.5.1 Overview

9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10. APAC Immunohistochemistry Market – Country Analysis

10.1 APAC Immunohistochemistry Market Revenue and Forecasts To 2028

10.1.1 Overview

10.1.2 APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.2.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.1.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.1.2.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.1.2.2 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.1.2.3 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.1.3 Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.1.3.1 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.1.4 Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.2.2.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.2.2.2 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.2.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.2.3 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.2.3.1 China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.2.4 China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.3 India Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.3.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.3.2.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.3.2.2 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.3.2.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.3.3 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.3.3.1 India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.3.4 India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.4.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.4.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.4.3.1 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.4.3.2 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.4.3.3 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.4.4 South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.5 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.5.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.2.5.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.5.2.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.5.2.2 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.5.2.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.5.3 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.5.3.1 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.5.4 Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.2.6 Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.2.6.2.1 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.2.6.2.2 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

10.1.2.6.2.3 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

10.1.2.6.3 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

10.1.2.6.3.1 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

10.1.2.6.4 Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on APAC Immunohistochemistry Market

11.1 APAC: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic developments

12.3.1 Overview

13. Company Profiles

13.1 Cell Signaling Technology, Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 MERCK KGaA

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 PerkinElmer Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 THERMO FISHER SCIENTIFIC INC.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Abcam plc

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 BIO-RAD LABORATORIES INC.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Danaher

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Bio SB

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 4. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 5. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6. Japan Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 7. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 8. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 9. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 11. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 12. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 14. China: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 15. China: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 16. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 18. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 19. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 21. India: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 22. India: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 23. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 25. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 26. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 28. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 29. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 30. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 31. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 32. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 33. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 34. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 35. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 36. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 37. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipment (US$ Mn)

Table 38. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 39. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 40. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)

Table 41. Rest of APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 42. Organic Developments Done By Companies

Table 43. Inorganic developments done by Companies

Table 44. Glossary of Terms

LIST OF FIGURES

Figure 1. APAC Immunohistochemistry Market Segmentation

Figure 2. APAC Immunohistochemistry Market Segmentation, By Country

Figure 3. APAC Immunohistochemistry Market Overview

Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5. India to Show Significant Growth During Forecast Period

Figure 6. APAC PEST Analysis

Figure 7. Impact Analysis of Drivers and Restraints Pertaining to APAC Immunohistochemistry Market

Figure 8. APAC Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9. APAC Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10. APAC Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. APAC Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. APAC Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. APAC Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. APAC Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. APAC Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. APAC Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. APAC Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. APAC Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. APAC Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. APAC Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. APAC Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. APAC Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. APAC Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. APAC Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. APAC Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. APAC Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. APAC Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. APAC Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. APAC Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30. APAC Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31. APAC Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32. APAC Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33. APAC Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34. APAC Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35. APAC Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36. APAC Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37. APAC Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38. APAC Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39. APAC Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. APAC Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. APAC Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. APAC Immunohistochemistry Market Overview, by Country (2021)

Figure 43. APAC: Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44. Japan: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45. China: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46. India: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47. South Korea: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48. Australia: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 49. Rest of APAC: Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Figure 50. Impact of COVID-19 Pandemic in APAC Country Markets

  1. Abcam plc
  2. Agilent Technologies, Inc.
  3. Bio SB
  4. BIO-RAD LABORATORIES INC.
  5. Cell Signaling Technology, Inc.
  6. Danaher
  7. F. HOFFMANN-LA ROCHE LTD.
  8. MERCK KGaA
  9. PerkinElmer Inc.
  10. THERMO FISHER SCIENTIFIC INC.    
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC immunohistochemistry market.    
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the APAC immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies  
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
TIPRE00025746
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.